已发表论文

年龄-胆红素-国际标准化比值(INR)-肌酐(ABIC)评分,PCI 后 CAD 患者长期死亡率的潜在预后模型

 

Authors Wu TT, Pan Y, Zheng YY, Yang Y, Hou XG, Deng CJ, Ma YT, Xie X 

Received 22 October 2022

Accepted for publication 30 December 2022

Published 26 January 2023 Volume 2023:16 Pages 333—341

DOI https://doi.org/10.2147/JIR.S394502

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Adam Bachstetter

Background: Given that age, international normalized ratio (INR), total bilirubin, and creatinine are reported to be independent risk factors for predicting outcome in patients with coronary artery disease (CAD), it is possible that the age–bilirubin–INR–creatinine (ABIC) score might be a potential prognostic model for patients with CAD.
Methods: A total of 6046 CAD patients after percutaneous coronary intervention (PCI) from the retrospective cohort study (Identifier: ChiCTR-ORC-16010153) were evaluated finally. The primary outcome long-term mortality and secondary endpoints mainly major adverse cardiovascular and cerebrovascular events (MACCEs) were recorded. Multivariate Cox regression models were used to determine risk factors for mortality and MACCEs.
Results: The ABIC score was significantly higher in the death group than in the survival group. After adjusting for other CAD risk factors, the ABIC score was identified to be an independent risk factor for long-term mortality by multivariate Cox analysis. When in the high ABIC group, the incidence of all-cause mortality would increased 1.7 times (adjusted HR=1.729 (1.347– 2.218), < 0.001), and 1.5 times for cardiac death (adjusted HR=1.482 (1.126– 1.951), =0.005).
Conclusion: The present study indicated that ABIC score≥ 7.985 predicts high long-term mortality and cardiac death risk for PCI patients. The ABIC score might be a potential prognostic model for patients with PCI.
Keywords: age–bilirubin–international normalized ratio–creatinine score, ABIC score, coronary artery disease, mortality, prognosis